158 related articles for article (PubMed ID: 21808110)
1. The burden of pneumococcal disease in children less than 5 years of age in Abu Dhabi, United Arab Emirates.
Howidi M; Muhsin H; Rajah J
Ann Saudi Med; 2011; 31(4):356-9. PubMed ID: 21808110
[TBL] [Abstract][Full Text] [Related]
2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
3. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
4. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
[TBL] [Abstract][Full Text] [Related]
5. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.
Ampofo K; Pavia AT; Stockmann CR; Blaschke AJ; Weng HY; Korgenski KE; Daly J; Byington CL
Pediatr Infect Dis J; 2011 Dec; 30(12):1100-3. PubMed ID: 22005513
[TBL] [Abstract][Full Text] [Related]
7. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.
Robinson KA; Baughman W; Rothrock G; Barrett NL; Pass M; Lexau C; Damaske B; Stefonek K; Barnes B; Patterson J; Zell ER; Schuchat A; Whitney CG;
JAMA; 2001 Apr; 285(13):1729-35. PubMed ID: 11277827
[TBL] [Abstract][Full Text] [Related]
9. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
10. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
13. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
14. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
[TBL] [Abstract][Full Text] [Related]
16. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
18. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
[TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study.
Ouldali N; Varon E; Levy C; Angoulvant F; Georges S; Ploy MC; Kempf M; Cremniter J; Cohen R; Bruhl DL; Danis K
Lancet Infect Dis; 2021 Jan; 21(1):137-147. PubMed ID: 32702302
[TBL] [Abstract][Full Text] [Related]
20. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
